VAERS reports by lot

GSK DTaP/Tdap lot T343J: VAERS reports

45 VAERS reports list lot T343J as a GSK DTaP/Tdap vaccine, received between 2023-06-28 and 2024-12-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1050%
Dermatological (non-injection-site)525%
Allergic / Anaphylactic210%
Neurological15%
Gastrointestinal15%
General / Systemic (non-local)15%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina5
Idaho4
Indiana3
New Jersey3
Texas3
Utah3
Tennessee2
California2
Washington2
Iowa2
Arizona1
Michigan1

Reports by month received

2023-061
2023-071
2023-084
2023-096
2023-113
2023-121
2024-013
2024-022
2024-035
2024-042
2024-055
2024-063
2024-071
2024-082
2024-091
2024-112
2024-123

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.